Gene: KIAA1958
Official Full Name: KIAA1958provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO16751 | KIAA1958 Knockout cell line (HeLa) | Human | KIAA1958 | 1:3~1:6 | Negative | Online Inquiry |
KO16752 | KIAA1958 Knockout cell line (HCT 116) | Human | KIAA1958 | 1:2~1:4 | Negative | Online Inquiry |
KO16753 | KIAA1958 Knockout cell line (HEK293) | Human | KIAA1958 | 1:3~1:6 | Negative | Online Inquiry |
KO16754 | KIAA1958 Knockout cell line (A549) | Human | KIAA1958 | 1:3~1:4 | Negative | Online Inquiry |
KIAA1958 Gene Knockout Cell Lines are genetically engineered cellular models specifically designed to facilitate the study of the KIAA1958 gene's function and its involvement in various biological processes. Through the use of CRISPR-Cas9 technology or similar genome-editing techniques, these cell lines lack functional copies of the KIAA1958 gene, enabling researchers to investigate the resulting phenotypic changes and elucidate the gene’s role in cellular pathways and disease mechanisms.
These knockout cell lines serve as powerful tools in understanding gene function by allowing scientists to observe alterations in cellular behavior, signaling pathways, and metabolic profiles that arise from the absence of KIAA1958. This inquiry is crucial in multiple research domains, including cancer biology, neurobiology, and developmental studies, particularly since KIAA1958 has been implicated in several conditions, including intellectual disability and neurodevelopmental disorders. Its role as a potential tumor suppressor also renders these cell lines significant for cancer research.
Compared to traditional methods of gene manipulation, KIAA1958 Gene Knockout Cell Lines offer several distinct advantages. They provide a stable and reproducible model system that is easy to handle, allowing for high-throughput applications and consistent results across experiments. Furthermore, the availability of these knockout lines facilitates a deeper understanding of gene interactions, which cannot be achieved through primary cells or transient transfection methods.
The introduction of these specialized cell lines is particularly valuable not only for basic research but also for translational studies, paving the way for potential therapeutic strategies targeting the KIAA1958 pathway. For researchers and clinicians who rely on precise, genetically modified models to derive insights into gene functions and disease mechanisms, KIAA1958 Gene Knockout Cell Lines represent an essential resource.
Our company, known for its commitment to advancing scientific research through innovative bioproducts, offers these knockout cell lines as part of an extensive product line. With a focus on delivering high-quality, reliable biological tools, we empower researchers to make groundbreaking discoveries that could lead to transformative developments in medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.